- Home
- HROW vs HEPS Comparison
HROW vs HEPS Comparison
Compare HROW & HEPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HROW
- HEPS
- Stock Information
- Founded
- HROW 1998
- HEPS 2000
- Country
- HROW United States
- HEPS Turkey
- Employees
- HROW N/A
- HEPS N/A
- Industry
- HROW Biotechnology: Pharmaceutical Preparations
- HEPS Catalog/Specialty Distribution
- Sector
- HROW Health Care
- HEPS Consumer Discretionary
- Exchange
- HROW Nasdaq
- HEPS Nasdaq
- Market Cap
- HROW 1.1B
- HEPS 883.5M
- IPO Year
- HROW N/A
- HEPS 2021
- Fundamental
- Price
- HROW $34.93
- HEPS $2.78
- Analyst Decision
- HROW Strong Buy
- HEPS
- Analyst Count
- HROW 7
- HEPS 0
- Target Price
- HROW $61.83
- HEPS N/A
- AVG Volume (30 Days)
- HROW 368.3K
- HEPS 378.9K
- Earning Date
- HROW 08-06-2025
- HEPS 05-08-2025
- Dividend Yield
- HROW N/A
- HEPS N/A
- EPS Growth
- HROW N/A
- HEPS N/A
- EPS
- HROW N/A
- HEPS N/A
- Revenue
- HROW $212,858,000.00
- HEPS $1,471,066,066.00
- Revenue This Year
- HROW $44.89
- HEPS $23.29
- Revenue Next Year
- HROW $38.22
- HEPS $25.43
- P/E Ratio
- HROW N/A
- HEPS N/A
- Revenue Growth
- HROW 53.49
- HEPS 42.87
- 52 Week Low
- HROW $20.85
- HEPS $2.11
- 52 Week High
- HROW $59.23
- HEPS $4.05
- Technical
- Relative Strength Index (RSI)
- HROW 70.24
- HEPS 50.57
- Support Level
- HROW $30.81
- HEPS $2.75
- Resistance Level
- HROW $33.27
- HEPS $2.90
- Average True Range (ATR)
- HROW 1.37
- HEPS 0.09
- MACD
- HROW 0.09
- HEPS -0.00
- Stochastic Oscillator
- HROW 88.78
- HEPS 48.00
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
About HEPS D-Market Electronic Services & Trading
D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. The Group derives revenue from the sales of goods, marketplace revenues and other revenues.